RPID
Rapid Micro·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Ample Liquidity
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About RPID
Rapid Micro Biosystems, Inc.
An innovative life sciences technology company that provides mission-critical automation solutions for the manufcturing and safe release of healthcare products
Life Science Tools and Services
12/29/2006
07/15/2021
NASDAQ Stock Exchange
163
12-31
Common stock
25 Hartwell Avenue, Lexington, MA, 02421
--
Rapid Micro Biosystems, Inc., was incorporated under the laws of the State of Delaware on December 29, 2006. The company is an innovative life science technology company that provides automated solutions to facilitate the efficient manufacturing and rapid, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injections. The Company develops, manufactures and sells proprietary consumables for Growth Direct systems, laboratory information management systems (" LIMS ") connectivity software and services to address rapid microbiological analysis for quality control in the manufacturing of pharmaceuticals, medical devices and personal care products. The company currently sells to customers in North America, Europe and Asia.
Earnings Call
Q1/2025
Estimate EPS-0.27
Actual EPS-0.26
Estimate Revenue6.63M
Actual Revenue7.21M
Contradictions Unveiled: Examining Tariff Effects, AI Integration, and Market Demand from XXX's Q1 2025 Earnings Call
May 20,2025 02:24
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.26
Actual EPS-0.27
Estimate Revenue7.03M
Actual Revenue7.30M
Rapid Micro Biosystems' Q2 2025: Navigating Contradictions in Pharma Decisions, Market Demand, and Growth Prospects
Aug 12,2025 10:57
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
RPID has released its 2025 Q3 earnings. EPS was reported at -0.26, versus the expected -0.25, missing expectations. The chart below visualizes how RPID has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
RPID has released its 2025 Q3 earnings report, with revenue of 7.84M, reflecting a YoY change of 3.08%, and net profit of -11.51M, showing a YoY change of -1.61%. The Sankey diagram below clearly presents RPID's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
